Antidepressant Drugs and COVID-19: A Review of Basic and Clinical Evidence

The COVID-19 pandemic has encouraged the repurposing of existing drugs as a shorter development strategy in order to support clinicians with this difficult therapeutic dilemma. There is evidence to support the theory that some antidepressants can reduce concentrations of different cytokines in human...

Descripción completa

Detalles Bibliográficos
Autores principales: Mas, Marta, García-Vicente, Juan Antonio, Estrada-Gelonch, Anaïs, Pérez-Mañá, Clara, Papaseit, Esther, Torrens, Marta, Farré, Magí
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9319396/
https://www.ncbi.nlm.nih.gov/pubmed/35887802
http://dx.doi.org/10.3390/jcm11144038

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9319396/
https://www.ncbi.nlm.nih.gov/pubmed/35887802
http://dx.doi.org/10.3390/jcm11144038

Ejemplares similares